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The Surgical Implications of the Posttransplant 
Lymphoproliferative Disorders 
A.C. Stieber, O. Boillot, C. Scotti-Foglieni, M.A. Nalesnik, R.D. Gordon, I. Marino, V. Mazzaferro, 
and T.E. Starzl 
THE posttransplant Iymphoproliferative disorders IPTLDs) represent a category of neoplastic·like con· 
ditions that occur in approximately 2<if to 2jCii of the 
transplant population. I PTLDs have been described in 
transplant patients receiving all types of solid organ 
grafts. 1·7 Several complications result from the presence of 
PTLDs and their treatment. Although primarily of medical 
interest. Iymphoproliferative disorders have important sur· 
gical implications both of a diagnostic and a therapeutic 
nature. Here we report our experience with the surgical 
implications of PTLDs in a large series of liver transplant 
patients. 
MATERIALS AND METHODS 
Forty·six patients of a total population of I ~TS tJ.67c' with 
orthotopic liver transplants IOLT) who received transplants be· 
tween January I. 19n and December 31. 1988 allhe University of 
Colorado at Denver and the University of millsbu~h developed 
PTLDs. This percentage represents less than one·halfthe cases of 
PTLD in patients with transplants of various solid organs at our 
center. However. the decision was made to analyze only those 
PTLD arising in OL T patients up to the end of 1988. in order to 
have a relatively homogenous population and a follow-up of at 
least 18 months. The immunosuppression consisted of azathio-
prine ([muran) in combination with sterOids and antilymphocyte 
globulin (ATGl until 1980. cyclosporine A CCyAI and steroids 
after 1980. with the addition of aZathioprine and monoclonal ATG 
lOKT3; Onhoclone. Raritan. NJI as needed for the treatment of 
acute rejecllon episodes. Thiny-six of these patients (78.3'( I had 
some form of surgery related to PTLDs t Fig lal. The Epstein-Barr 
virus (EBV) and herpes simplu virus (HSVI statu~ were checked 
in almost all the patients. In well studied patients. the a~sociation 
of EBV and PTLD was almost universal. I.' 
RESULTS 
The condition was diagnosed an average of 17 months after 
the transplant (range. 0.75-153 months. median 4 monthsl. 
The organ or organ-systems involved were lymph nodes 
(including tonsils. in 30 patients (65.2%). gastrointestinal 
tract in 15 patients (32.6CiiI. homograft liver in 9 (19.6CiiI. 
other solid organs in 11 (23.9Iii I. and other sites in 418. 7<if) 
(Fig 2al. 
In 18 patients (39.1%) the tumors had a nonclonal 
character. in 14 patients (30.4Cii) clonal. while in 14 pa-
lients (30.4Cii) the character of the PTLD was mixed or 
could not be determined with accuracy (Fig 2bl. 
The EBV status was positive for primary infection or 
reactivation of old disease at the time of the PTLD in 40 
patients (87%). negative in 2 patients (4.3%1. and unknown 
in 4 (8.7%) <Fig 2c). 
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Fig 1. 
Thirty-six patients 178.3%) had some surgical procedure 
related to PTLDs: 19 patients (41J<if) had a superficial 
lymph node biopsy. 5 patients II 9. 2 <if I had exploratory 
laparotomy. 9 patients (19.6t;f) had some gastrointestinal 
tract resection. 3 patients (6.5<if. had resection of a solid 
tumor (including one patient who had a native nephrecto· 
my). and 7 patients (15.2%) had punch or needle biopsy 
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(Fig I b). Some of these patients had more than one 
procedure. 
Although there was a total of ~P deaths /SO'I() in this 
group. only 6 patients (131)t) died as a direct result of the 
PTLD. and none of the deaths could be attributed to the 
surgical intervention itself. Nine patients ( 19.6t;1) died of 
sepsis. and 8 patients ( 17.4t;1) died of various other causes 
(for ego cardiorespiratory arres\. multiple organ failure. 
hemorrhage. and drowning in one patient) (Fig 3a). None 
of these 17 patients had evidence of PTlD at the time of 
their death. All survivors are apparently free of disease at 
the present time. 
Eleven patients (23.9lft) were treated by decreasing their 
immunosuppressive drug dosages (one also received al-
pha-interferon (a-IFNI> and 5 (45.St;1, are still alive. 
Twel\e patients (26.1'k1 had their immunosuppressive 
drugs decreased. as well as high dose acyclovir or a-IFN 
therapy: 6 (SO'k) are still alive. Five patients (IO.7t;1) were 
treated with a decrease of their immunosuppression com-
bined with resection of at least one tumoral mass and all 
(\ooq I survived. Five patients (10.7%) were treated with 
immunosuppression reduction. high dose acyclovir. and 
resection: they are all alive (100C7c). One patient (2.21)t) had 
immunosuppression reduced and conventional chemother-
apy without survival. One patienl (2.211) was treated with 
immunosuppression reduction. conventional chemother-
apy. and resection: she survived tumor-free for S years. 
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but died of sepsis 6 years after OLT. Finally one r"tient 
(2.21)t I was onh' treated with resectional therap~ and 
survived (Fig 3bl. Ten patients C!1.7t;1) were diagno~d as 
having PTLD only at the postmortem examination. 
DISCUSSION 
It is now quite clear that PTlDs are the end result of the 
modification~ caused by the antirejection therapy on the 
host immune system. All major immunosuppressive d~gs 
(CyA. azathioprine. antilymphocytic globulin prerara-
tions. and monoclonal antibodies) have been m:pli-
cated. ~Ia The mechanisms known or presumed t(\ be 
implicated in the de\'eIopment of PTLDs have been n:en-
sively studied. U.Y 
Two factors complicate the management: (I) since 
PTLDs are a result of overimmunosuppression. treatmtnt 
with conventional antineoplastic chemotherapy could ac-
celerate the process: and (2) the reduction or discontinua-
tion of the immunosuppression. with the purpose of ree<;-
tablishing the host defenses ma}' result in graft rejection. 
The essence of mana@lement is to allow enough immune 
reconstitution to permit oncologic surveillance to be esLlb-
lished. while maintaining graft function. The balance may 
be favorably altered by treatment with acyclovir. since the 
tumors have a viral etiology. 10.11 
Surgical intel'\'ention in transplant patients who develop 
L YMPHOPROLIFERATlVE DISORDERS 
PTLDs is done either for diagnostic or therapeutic pur-
poses. 
Diagnostic biopsie~ were performed in 21 patients. In 
addition. clinical criteria (high index of suspicion. lymph-
adenopathy by CT s.:an. elevated uric acid levels l ) were 
also taken into consideration. Biopsies allow both accurate 
diagnosis and classification I. 7 of the lesions. with the 
polyclonal disorders having a better prognosis. 1.1.7 
In nine patients. the surgical intervention had a thera-
peutic purpose. This was either intended as a primary 
resection of involved tissue with the goal of eradicating 
residual tumor or as a means of dealing with PTLD 
complications. Small bowel perforation was characteristic 
in patients with gastrointestinal involvement. The perfora-
tions commonly occurred during the early remission 
phase. presumably \I, hen transmural lesions were under-
going necrosis. 
The accepted treatment of PTLDs is a reduction or 
temporary suspension of the immunosuppressive regimen. 
coupled with adjunctive chemotherapy with acyclovir. 
The early attempts at treatment with conventional antineo-
plastic chemotherapy lead to worsening of the patients' 
condition and death. < This is easily e\plainable on basis of 
the theory that the posttransplant Iymphoproliferative dis-
orders are the result of immunosuppression. Conventional 
chemotherapy adds its immunosuppressive effect to that of 
the antirejection therapy. thus preventing the body's de-
fenses from successfully fighting the EBV-triggered neo-
plastic process. The underlying theme in patients with 
PTLD is thus an overimmunosuppressed status. This not 
only results in the I} mphoproliferative disorder itself. but 
also leads to frequently lethal septic complications. In fact. 
sepsis was the most frequent cause of immediate or 
delayed death in our group. 
Isolated visceral tumors can behave like ordinary gas-
trointestinal lymphomas. in the sense that an adequate 
local resection can be curative in many patients. even if the 
tumor has not regressed \I, ith reduction of the immunosup-
pression and acyclo\ir. Patients with these tumors hal .. e 
benefited from aggressive surgical resection: 12 of 24 
patients treated only medkally (S<YC) survived as com-
pared with II of 12 (91. 7C;( I treated \10 ith a combination of 
medical manipUlation and surgical resection (p < .(01) 
(Fig 3c). Thus surgery emerges as a very pO\loerfultool in 
the treatment of PTLDs. 
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If operation is not perf()fl11ed in such cases. high index of 
suspicion and careful m\."\nitoring are necessary in order to 
diagnose early the occurrence of perforation. The patient 
is probably not "safe" until the complete disappearance of 
the mass has been documented by CT scan or endoscopy. 
Tonsillar involvement has been frequent in the pediatric 
age group: consequentl~ . tonsillectomy often has been the 
means for diagnosing PTLD in children. However. the 
danger of postoperati, e edema with acute respiratory 
distress dictates that onl~ a unilateral tonsillectomy should 
be performed if the pnxedure is primarily for diagnostic 
purposes. Now that the disease can be treated so well by 
medical means. tonsille-.=tomy is not often indicated any 
longer. 
The mortality of liver transplant recipients with PTLDs 
has been higher than that for kidney transplant recip-
ientsl.<·': higher immunosuppressive drug doses. more 
generalized organ invo" ement. and above all. deteriora-
tion of a vital graft without artificial organ support account 
for this difference. 
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